Skip to main content
OpenTrials
Completed

NCT Number: NCT05636449

Suprainguinal Fascia Iliaca Block vs. Periarticular Injection for Total Knee Arthroplasty

Total knee replacement (total knee arthroplasty) is performed to resurface a knee damaged by arthritis and relieve pain in patients with severely damaged knee joints.

Total knee arthroplasty (TKA) is associated with severe postoperative pain, and the management of postoperative pain continues to evolve with the advancement of surgical techniques and pharmacological treatments.

Femoral, lateral femoral cutaneous nerve and obturator nerve block is provided with suprainguinal fascia iliaca plan block, which is used for postoperative analgesia, especially in hip surgeries. In this way, the investigators think it can be used as a part of multimodal analgesia in total knee arthroplasty surgery.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Analgesia Agnosia Nervous System Diseases Neurobehavioral Manifestations Neurologic Manifestations Pathological Conditions, Signs and Symptoms Perceptual Disorders Signs and Symptoms

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Ali Ahiskalioglu

Erzurum, 25100, Turkey (Türkiye)

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • American Society of Anesthesiologist's physiologic state I-III patients
  • Total knee arthroplasty

Exclusion criteria

  • BMI>35
  • liver, kidney, and advanced heart failure,
  • routine use of analgesics and
  • having used analgesics in the last 24 hours,
  • having neuropathic pain,
  • refusal to participate in the study

Treatment and study plan

Group Suprainguinal fascia iliaca block

Other

After the operation is completed, the fascia iliaca will be separated from the iliacus muscle. With ultrasound guidance, the local anesthetic injection will be made between the fascia and the muscle.

Group Periarticular Infiltration

Other

A total volume of 80 ml local anesthetic will be applied to the medial and lateral capsule, the medial and lateral meniscus margins, the deep part of the medial ligament, the medial and lateral synovial space, and the patellar ligament and quadriceps tendon.

Primary outcomes

  1. Postoperative opioid consumption

    Time frame: first 24 hours

    First 24 hours total fentanyl consumption with patient controlled analgesia

Secondary outcomes

  1. Visual analog pain score

    Time frame: first 48 hours

    Post operative pain will be evaluated with a Visual Analogue Scale (between 0-10; 0: no pain, 10:worst pain) score

  2. timed up and go test (TUG)

    Time frame: at 24th hour

    TUG- evaluation of the time in seconds for the patient to get up from the chair and walk 3 meters and return to the chair again

  3. quadriceps muscle strength

    Time frame: at 24th hour

    will be evaluated in a scale between 1-5 (1:lowest; 5:normal)

  4. joint range of motion test (ROM)

    Time frame: at 24th hour

    will be measured with goniometer( between 0-180 degrees)

  5. Five Time Sit to Stand Test (FTSST)

    Time frame: at 24th hour

    physical assistance of the patient getting up and sitting down 'as fast as possible' five times without

Sponsors and collaborators

Lead sponsor

Ataturk University

Other

Registry information

Official study title

Ultrasound Guided Suprainguinal Fascia Iliaca Block vs. Periarticular Injection for Total Knee Arthroplasty: Prospective Randomized Study

Important dates

Study start
2022
Primary completion
2023
Study completion
2023
First posted
Dec 5, 2022
Registry last updated
Jun 18, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.